Gulinigaer Anwaier, Gulinigaer Anwaier, Gulinigaer Anwaier, Gulinigaer Anwaier, Gulinigaer Anwaier, Gulinigaer Anwaier, . . . Jian Liu. (2022). QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19/TGF-β1 Signaling Pathway. Frontiers Media S.A..
Chicago Style (17th ed.) CitationGulinigaer Anwaier, et al. QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19/TGF-β1 Signaling Pathway. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationGulinigaer Anwaier, et al. QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19/TGF-β1 Signaling Pathway. Frontiers Media S.A., 2022.